BioSpace News Archive

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that it will participate in the following virtual conferences in August

Ionis Pharmaceuticals, Inc. reported its financial results for the second quarter of 2020 and recent business highlights.

Intec Pharma Ltd. announces financial results for the second quarter ended June 30, 2020 and provides a corporate update.

Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced its financial results for the second quarter ended June 30, 2020.

CorVent Medical, a Coridea portfolio company focused on developing smart, versatile, lifesaving ventilators for critical care, announced the appointment of Richard S. Walsh to Chief Executive Officer.

InMode Ltd., a leading global provider of innovative medical technologies, announced consolidated financial results for its second quarter ended June 30, 2020.

Progress across pipeline continues with BT1718 Phase IIa and BT8009 Phase I/II trial initiations on-track for this year

AmerisourceBergen Corporation reported that in its fiscal year 2020 third quarter ended June 30, 2020, revenue increased 0.3 percent year-over-year to $45.4 billion.

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that Derek Maetzold, president and chief executive officer, is scheduled to present a company overview at the Canaccord Genuity 40 th Annual Growth Conference o

Participating investors include funds and accounts managed by BlackRock, GV (formally Google Ventures), Invus, Casdin Capital, Franklin Templeton, Octagon Capital, Perceptive Advisors LLC, Sands Capital, ArrowMark Partners, Venrock Healthcare Capital Partners, PBM Capital and Nolan Capital